Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-27

Clinical Trial Update: Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating the efficacy of Faricimab for age-related macular degeneration, diabetic macular edema, and retinal vein occlusion in Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VABYSMO (faricimab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Age-Related Macular Degeneration, Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN